We verified the analytical performance of the Abbott RealTi m e SARS-CoV-2 assay on the m 2000 system and compared its clinical performance to the CDC 2019-nCoV real-time PCR diagnostic panel and the Thermo Fisher TaqPath RT-PCR COVID-19 kit. We also performed a bridging study comparing the RealTi m e SARS-CoV-2 assay with the new Abbott Alinity m SARS-CoV-2 assay.
No takes yet. Share an insight, caveat, or question.
Hirschhorn et al. (2021) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: